Table 6.
Effect of embolic agent on uterine volume, diameter of largest fibroid, infarction rate and uterine artery patency
| Embospheres | Gelfoam | Difference between groups (E-G)*** | |||||
|---|---|---|---|---|---|---|---|
| Baseline* | 6 months* | Change** | Baseline* | 6 months* | Change** | ||
| Uterine volume (cc) | 1018 (666) | 622 (436) | − 257 (− 398 to − 115) p = 0.001 | 1026 (756) | 908 (720) | − 117 (− 286 to 52) p = 0.15 | −281 (− 496 to − 66) p = 0.01 |
| Largest fibroid diameter (cm) | 9.2 (3.8) | 7.3 (3.4) |
− 2.0 (− 3.0 to − 1.0) p = 0.002 |
9.5 (4.8) | 8.8 (5.9) |
−0.7 (− 1.9 to 0.5) p = 0.20 |
−1.3 (− 2.7 to 0.2) p = 0.09 |
| Uterine artery | 10 (100%) | 10 (10%) | |||||
| Complete infarction (100%) | 5 (50%) | 2 (20%) | |||||
| Almost complete infarction (99–90%) 99–90%) | 3 (30%) | 1 (10%) | |||||
| Incomplete infarction (< 90%) | 2 (20%) | 7 (70%) | |||||
*Mean (SD)
**Mean of change over time calculated as 6 month – baseline, 95% CI of change, p-value
***Mean difference between embolic agents at 6 months adjusted for baseline values, 95% CI of difference. Positive values indicate higher results in the E group